{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:13:45Z","timestamp":1794500025619,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.drugalcdep.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T16:35:57Z","timestamp":1512664557000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"special_numbering":"C","title":["Kratom use and mental health: A systematic review"],"prefix":"10.1016","volume":"183","author":[{"given":"Marc T.","family":"Swogger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: kratom (Mitragyna speciosa) exposures reported to poison centers \u2014 United States, 2010\u20132015","volume":"65","author":"Anwar","year":"2016","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jep.2012.03.009","article-title":"Mitragyna speciosa use in the northern states of Malaysia: a cross-section","volume":"7","author":"Ahmad","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00012995-198606000-00001","article-title":"Adverse effects of prolonged benzodiazepine use","volume":"118","author":"Ashton","year":"1986","journal-title":"Adverse Drug React. Bull."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0020","series-title":"The Chemistry and Pharmacoogy of Opioids from a Non-opium Source","first-page":"309","article-title":"Kratom: the epidemiology, use and abus, addiction potential, and legal status. kratom and other mitragynines","author":"Aziz","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0025","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999\u20132010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0030","series-title":"Kratom: The Supplement That Will Kill Godzilla Topic","author":"Bloom","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/968786","article-title":"Following the roots of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in western countries","volume":"2015","author":"Cinosi","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0045","unstructured":"Drug Enforcement Administration, August 30, 2016. \u201cDEA announces intent to schedule kratom. Retrieved March 20, 2017, from https:\/\/www.dea.gov\/divisions\/hq\/2016\/hq083016.shtml."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0050","unstructured":"Erowid, 2017. Erowid experience vaults: kratom (also mitragyna speciosa) reports. Retrieved February 14, 2017, from https:\/\/erowid.org\/experiences\/subs\/exp_Kratom_General.shtml."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550887.2013.854153","article-title":"Kratom exposures reported to texas poison centers","volume":"32","author":"Forrester","year":"2013","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of kratom use and health impact in the US: results from an online survey","volume":"176","author":"Grundman","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0065","series-title":"High Price: A Neuroscientist\u2019s Journey of Self-discovery That Challenges Everything You Know About Drugs and Society","author":"Hart","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From kratom to mitragynine and its derivatives: physiological and behavioral effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0075","series-title":"Assessment of Kratom Under the CSA Eight Factors and Scheduling Recommendations","author":"Henningfield","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","article-title":"Cognitive behavioral therapy for adult anxiety disorders: a meta-analysis of randomized, placebo-controlled, trials","volume":"68","author":"Hofman","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13181-011-0155-5","article-title":"Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa)","volume":"7","author":"Kapp","year":"2011","journal-title":"J. Med. Toxicol."},{"issue":"November","key":"10.1016\/j.drugalcdep.2017.10.012_bib0090","first-page":"2016","article-title":"A meta-analysis of third-wave mindfulness-based cognitive-behavioral therapies for older adults","volume":"11","author":"Kishita","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/NDT.S56441","article-title":"Suicide risk among Thai illicit drug users with and without mental\/alcohol use disorders","volume":"13","author":"Kittiranapaiboon","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0100","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PRA.0000000000000154","article-title":"Buprenorphine prescribing: to expand or not to expand","volume":"22","author":"Li","year":"2016","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/dar.12323","article-title":"Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: the impact of contextual factors","volume":"35","author":"Lucas","year":"2016","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0115","series-title":"The War on Drugs: a Failed Experiment","author":"Mallea","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jat\/bku137","article-title":"mitragynine \u2018kratom' related fatality: a case report with postmortem concentrations","volume":"39","author":"McIntyre","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0125","series-title":"Qualitative Research: A Guide to Design and Implementation","author":"Merriam","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0130","first-page":"1","article-title":"Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment","volume":"16","author":"Miranda","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0135","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1111\/1556-4029.12009","article-title":"A drug fatality involving kratom","volume":"58","author":"Neerman","year":"2012","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13181-010-0079-5","article-title":"Seizure and coma following kratom (Mitragynina speciosa korth) exposure","volume":"6","author":"Nelsen","year":"2010","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0145","series-title":"Pharmakognosis: Plant Teachers and the Poison Path","author":"Pendell","year":"2010"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1192\/bjp.bp.108.051110","article-title":"Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study","volume":"195","author":"Price","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0155","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic, and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1037\/0022-3514.69.4.719","article-title":"The structure of psychological well\u2013being revisited","volume":"69","author":"Ryff","year":"1995","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0165","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings","author":"(SAMHSA) Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.drugpo.2012.09.004","article-title":"Pattern and consequences of krathom (Mitragyna speciosa Korth) use among mail villagers in southern Thailand: a qualitative study","volume":"24","author":"Saingam","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/08897077.2014.924464","article-title":"Validation of Kratom (Mitragyna speciosa Korth) dependence scale (KDS): a dependence screen for internationally emerging psychoactive substance","volume":"35","author":"Saingam","year":"2014","journal-title":"Subst. Abuse."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/02791072.2016.1156791","article-title":"Factor analytical investigation of krathom (Mitragyna speciosa Korth) withdrawal syndrome in Thailand","volume":"48","author":"Saingam","year":"2016","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-014-0017-3","article-title":"Sex difference in mood disorders: perspectives from humans and rodent models","volume":"5","author":"Seney","year":"2014","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ADM.0b013e318221fbfa","article-title":"A coincidence of addiction to kratom and severe primary hypothyroidism","volume":"5","author":"Sheleg","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02791072.2015.1012610","article-title":"Social functioning of kratom (mitragyna speciosa) users in Malaysia","volume":"47","author":"Singh","year":"2015","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainresbull.2016.05.004","article-title":"Traditional and non-traditional uses of Mitragynine (Kratom): a survey of the literature","volume":"126","author":"Singh","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addbeh.2017.04.006","article-title":"Intentional cannabis use to reduce crack cocaine use in a Canadian center: a longitudinal analysis","volume":"72","author":"Socias","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.drugalcdep.2016.11.018","article-title":"Prescription opioids: new perspectives and research on their role in chronic pain management and addiction","volume":"173","author":"Stitzer","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","article-title":"Experiences of kratom users: a qualitative analysis","volume":"47","author":"Swogger","year":"2015","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0262-4079(16)31929-7","article-title":"A ban too far","volume":"232","author":"Swogger","year":"2016","journal-title":"New Sci."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0230","series-title":"Kratom in Thailand, Decriminalization and Community Control. Series on Legislative Reform of Drug Policies. Nr 13","author":"Tanguay","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/02791072.2013.844532","article-title":"Kratom abuse in ramathibodi poison center, Thailand: a five-year experience","volume":"45","author":"Trakulsrichai","year":"2013","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","article-title":"The informal use of Ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy","volume":"21","author":"Vicknasingam","year":"2010","journal-title":"Int. J. Drug Policy."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: a guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2017.10.012_bib0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/11596830-000000000-00000","article-title":"Herbal medicines for the management of opioid addiction","volume":"25","author":"Ward","year":"2011","journal-title":"CNS Drugs"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:23:00Z","timestamp":1536272580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617305586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"alternative-id":["S0376871617305586"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.012","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kratom use and mental health: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}